NJ-based Johnson & Johnson expects to release early data next week from Phase 3 clinical trials
New Brunswick-based Johnson & Johnson says it expects to release early data next week from the Phase 3 clinical trials of its vaccine.
News 12 Staff
•
Jan 28, 2021, 10:56 AM
•
Updated 1,182 days ago
Share:
More Stories
Hometown Heroes in New Jersey
8ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
205ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
217ds ago
Murphy administration: No plans to implement any COVID-19 restrictions
223ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
224ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
226ds agoHometown Heroes in New Jersey
8ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
205ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
217ds agoMurphy administration: No plans to implement any COVID-19 restrictions
223ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
224ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
226ds agoNew Brunswick-based Johnson &
Johnson says it expects to release early data next week from the Phase 3
clinical trials of its vaccine.
The company came to an
agreement over the summer with the federal government to deliver 100 million
doses after getting approval for usage.
Johnson & Johnson's
vaccine only requires one shot, unlike the currently available vaccines by
Pfizer and Moderna.
